Mutations in PIK3CA (25.9%), INPP5B (30.8%), SRC (99%) and TSC2 (46.7%) were observed in Tumor #3, and Tumor #4 harbored an NF1 gene mutation (43.5%). The gene discussed is TSC2; the disease is neoplasm.